Mestrado em Assistência Farmacêutica
URI Permanente para esta coleção
Navegar
Submissões Recentes
- ItemSintomas depressivos no ambiente universitário no contexto da pandemia por Covid-19: achados e implicações(Universidade Federal do Espírito Santo, 2024-06-14) Peixoto, Meiriane; Meira, Fabiana Dayse Magalhães Siman; http://lattes.cnpq.br/9468453605243748; Silva, Michael Ruberson Ribeiro da; https://orcid.org/0000-0003-2550-7249; http://lattes.cnpq.br/2822520981120774; https://orcid.org/0000-0003-3981-395X; http://lattes.cnpq.br/8234350262120642; Marques, Luciene Alves Moreira; Barreto, Ana Claudia GamaIntroduction: Depression is the most common mental disorder and is considered the leading cause of disability and premature death worldwide. Data from the World Health Organization (WHO) reveal that over 322 million people are affected by depression. Recently, the COVID-19 pandemic has been considered a factor that can increase and/or exacerbate symptoms indicative of depression. As a result, the university population has been a target of study due to the significant impact that mental disorders have on academic life. Objective: To analyze the prevalence of depression among students and staff at Brazilian Higher Education Institutions (HEIs). Methods: The first phase is na epidemiological, observational, cross-sectional, analytical, individual study comprising public servants, undergraduates, and postgraduates from the Alegre campus of the Federal University of Espírito Santo, conducted from June to October 2020. Participants responded to an online questionnaire that included variables such as academic trajectory, sociodemographic data, lifestyle habits, health conditions, and the Beck Depression Inventory (BDI). The collected data were analyzed using descriptive statistics with the aid of SPSS® version 20. The second phase of the study involves a systematic literature review, registered in PROSPERO, conducted in the Medline via PubMed, LILACS, Scielo, and Embase databases using descriptors from Medical Subject Headings (MeSH), Health Sciences Descriptors (DeCS), and EMTREE terms, following the PRISMA guideline recommendations and the Joanna Briggs Institute Critical Appraisal tool for bias analysis of the publications. Cross sectional studies published in Portuguese, English, or Spanish, measuring the prevalence of depression among the university population, and published between 2020 and 2023 met the inclusion criteria. Subsequently, two independent researchers evaluated titles, abstracts, full texts, and extracted data. Results: The sample (first phase) comprised 519 participants: 15.6% faculty, 5.6% public servants, 71.5% students, and 7.3% postgraduates. The data revealed a high prevalence of depressive symptoms before the pandemic (37.4%) compared to the general population, with a significant increase during the pandemic period (44.9%) (p-value<0.05). The main risk factors associated with depressive symptoms were female sex and smoking. The majority of the population is female (68.2%), with 74.8% single, living in shared housing (40.7%), and with a predominant family income of 1 to 3 minimum wages (61.1%). Most participants are from the Center for Exact, Natural, and Health Sciences (CCENS), with the pharmacy course being the most represented (11.3%). In the systematic review, out of 96 identified records, 10 articles met the eligibility criteria. The studies were conducted in public and private universities across all regions of the country. The predominant methodological design was cross-sectional (n=9), with one study being a qualitative-quantitative investigation (n=1). The sample sizes ranged from 217 to 5985 participants, comprising undergraduates, postgraduates, and staff. The prevalence found ranged from 10.1% to 81.0%. Three studies analyzed undergraduates from health-related courses (pharmacy, dentistry, and medicine), and only one study analyzed all three populations together. The most commonly used instrument to assess prevalence was the Depression, Anxiety, and Stress Scale (DASS-21). Conclusion: The data presented in the first article reveal a high prevalence of depression in the university population at UFES Alegre campus, exacerbated during the pandemic period and associated with females and smokers. The systematic review data corroborated the findings of the first article regarding the pandemic period; however, the analyzed population included universities from across the country. Therefore, the results indicate the need for prevention, care and support measures for the academic and can be used to support future projects for university and public health policies to address the psychological distress of the university population.
- ItemPerspectivas dos profissionais de saúde quanto aos cuidados da população transgênero na Atenção Primária à Saúde: uma revisão de escopo(Universidade Federal do Espírito Santo, 2025-03-20) Souza, Jayne Menezes de; Detoni, Kirla Barbosa; https://orcid.org/0000-0003-0651-3547 ; http://lattes.cnpq.br/4658617742317519; Rocha, Kérilin Stancine Santos; https://orcid.org/0000-0002-2313-2140 ; http://lattes.cnpq.br/4216594263272412; https://orcid.org/0009-0002-6619-6977; http://lattes.cnpq.br/0195480308196211; Brito, Giselle de Carvalho; https://orcid.org/0000-0002-3982-2138; http://lattes.cnpq.br/0432751118102432; Jesus, Náila Neves de; https://orcid.org/0000-0003-3370-0639; http://lattes.cnpq.br/6566671970631957; Santos Júnior, Genival Araújo dos; https://orcid.org/0000-0002-5618-1846; http://lattes.cnpq.br/5917097187533724; Araújo, Dyego Carlos Souza Anacleto de; https://orcid.org/0000-0001-6631-465X; http://lattes.cnpq.br/5120426619544250; Santos, Sabrina Cerqueira ; https://orcid.org/0000-0001-6748-727X; http://lattes.cnpq.br/8757541282986479Introduction: Studies show that transgender individuals face significant barriers in the context of primary health care. The literature has explored the perspectives and experiences of transgender individuals regarding the care they receive; however, there is still no comprehensive view of health professionals' perspectives on this care. Objective: To map the perspectives of health professionals regarding the care of the transgender population in primary health care. Methods: A scoping review was conducted following the methodological processes proposed by the JBI Manual for Evidence Synthesis and the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A systematic search was carried out in May 2024 in the following databases: PubMed/Medline, Embase, Web of Science, Cinahl, Scielo, Virtual Health Library, the International Journal of Transgender Health, and the gray literature. Descriptors related to "Health Personnel," "Transgender Persons," and "Primary Health Care" were used. Subsequently, two reviewers independently selected the studies through title and abstract screening, followed by full-text analysis based on eligibility criteria. Data were extracted independently by two reviewers, and the professionals' perspectives were jointly analyzed by the review team and categorized. The data were presented descriptively. Results: A total of 1,022 studies were identified in the initial search, of which 11 articles met the eligibility criteria and were included in this review. Most studies were conducted in North American countries (n = 7; 63.6%) and had a qualitative design (n = 9; 81,8%). The analysis of healthcare professionals' perspectives resulted in the following categories: "Professional Attitude," addressed in 11 studies (100%), "Healthcare Network" (n = 10; 90,9%), "Training" (n = 9; 81,9%), and "Stigma" (n = 7; 63,3%). The main professionals participating in the studies were physicians and nurses. Strategies cited by professionals for promoting transgender care in primary health care focused on the professional and/or the healthcare team. Conclusion: The perspectives of professionals on the care of the transgender population in primary health care revealed that various aspects related to the Health Care Network, Training, Stigma, and Professional Attitudes influence this care. Significant challenges were identified, which may compromise the quality of care. Strategies focused on professionals and teams can be implemented to promote inclusive care
- ItemProdução de vídeos de educação em saúde para surdos : uma revisão de escopo(Universidade Federal do Espírito Santo, 2024-08-01) Salomão, Sthefany Brito; Bassan, Larissa Helyne ; https://orcid.org/0000-0002-6460-7878; http://lattes.cnpq.br/8455348679035377; Araújo, Dyego Carlos Souza Anacleto de ; https://orcid.org/0000-0001-6631-465X; http://lattes.cnpq.br/5120426619544250; https://orcid.org/0009-0008-8743-8780; http://lattes.cnpq.br/5011148219460466; Nunes, Deuzilane Muniz ; https://orcid.org/0000-0002-3037-2660; http://lattes.cnpq.br/9351254036991427; Galindo Neto, Nelson Miguel ; https://orcid.org/0000-0002-7003-165X; http://lattes.cnpq.br/0593074026473891Introduction: deaf people face barriers to communication and access to health information. Sign Language videos are effective tools for transmitting this information. However, there is no synthesis in the literature about the production process of these videos. Objective: to summarize the steps in the process of producing health education videos for the deaf. Methods: this is a scoping review, carried out in accordance with the recommendations of the JBI Manual for Evidence Synthesis for Scoping Reviews. The searches were carried out in December 2023, in PubMed/Medline, Embase, Scopus, Lilacs, Scielo and Google Scholar, using descriptors related to “deafness” and “health education”. Two researchers independently selected studies, by analyzing titles and abstracts and then full texts. Original studies were included, whose main objective was to develop and/or evaluate health education videos for the deaf, as long as the stages of the production process were described. The following articles were extracted: authors, year of publication, country, theme and steps and guidelines for producing educational video material for the deaf. Results: 1809 publications were identified in the initial search, of which 16 were included in this scoping review. The articles were published between 2009 and 2023, with the United States (n=7; 43.8%) and Brazil (n=5; 31.2%) being the countries with the highest number. The educational videos were especially about breast cancer (n=3; 18.8%); Sexual and reproductive education (n=3; 18.8%) and oral hygiene (n=2; 12.5). The synthesis of the steps and guidelines identified in the studies were summarized and structured as follows: i) pre-production, which consists of planning the video; ii) production, which includes the construction and recording of videos; iii) post-production, which includes editing and organizing recorded scenes, as well as validating the material produced. Conclusion: this scoping review summarized the stages of the process of producing health education videos for the deaf available in the literature, and can be used as a starting point by health educators
- ItemAvaliação do impacto do acompanhamento farmacoterapêutico a pessoas com hipertensão arterial em um município sul-capixaba : ensaio clínico pragmático(Universidade Federal do Espírito Santo, 2024-03-15) Alencar, Taiana de; Santos Júnior, Genival Araujo dos ; https://orcid.org/0000-0002-5618-1846; http://lattes.cnpq.br/5917097187533724; https://orcid.org/0009-0006-1916-9633; http://lattes.cnpq.br/7190658443957873; Oliveira Filho, Alfredo Dias de; https://orcid.org/0000-0003-3192-8285; http://lattes.cnpq.br/2692375096980574; Severi, Juliana Aparecida; https://orcid.org/0000-0001-7516-2395; http://lattes.cnpq.br/4265400222421660 ; Silva, Rafaella de Oliveira Santos; https://orcid.org/; http://lattes.cnpq.br/4008596465243842Introduction: Arterial hypertension (AH) is a chronic health condition that may require changes in lifestyle and the use of medication. However, this use is not without risks. In this context, the Pharmacotherapeutic Follow-up Service (FHS) has emerged as a strategy capable of improving the health outcomes of people with AH. However, there are few high-research studies on this subject. Objective: To assess the impact of FAS on the health outcomes of patients with AH in the health care network in the municipality of Alegre/ES. Method: This is an experimental single-blind randomized controlled clinical trial. People with hypertension who met the eligibility criteria (over 18 years of age, with self-reported hypertension, taking medication for hypertension for at least 6 months) were randomized in a 1:1 ratio to the intervention and control groups. They received FAS and usual care, respectively, for a period of 12 months. The study was conducted in the Health Care Network of the municipality of Alegre, Espírito Santo, Brazil, from January 2022 to November 2023. In both groups, primary outcomes (blood pressure and quality of life) and secondary outcomes (knowledge about hypertension, anthropometric profile and clinical examinations) were assessed at three points in time, six months apart. Ethical considerations were observed (CAAE registration number 13586319.6.0000.8151 | Opinion no. 4.732.878). Results: 128 patients were allocated to the intervention group (64) and the control group (64). Statistically significant differences were observed in the intra-group analysis in the intervention group, including SBP (∆ = -9.47 mmHg, p = 0.014), Total Cholesterol (∆ = -18.93 mg/dL, p = 0.001), LDL (∆ = -15.70 mg/dL, p < 0.001), non-HDL cholesterol (∆ = -19.76 mg/dL, p < 0.001) and cardiovascular risk (∆ = -1.82 points, p < 0.001). There was an increase in the score for knowledge about hypertension (∆ = 1.39 points, p < 0.001), an improvement in quality of life in the mental state subdimension (∆ = -2.76 points, p = 0.020) and somatic manifestations (∆ = -1.5 points, p = 0.012). In the control group, it was possible to observe an increase in the score for knowledge about hypertension (∆ = 1.52 points, p = 0.001) and an improvement in the VAS of the EQ5D (∆ = 10.33 points, p = 0.067). In addition, almost all the patients were satisfied or very satisfied with the service provided by the pharmacists. Conclusion: The results show a promising positive impact of FAS on clinical and humanistic parameters, as well as a reduction in cardiovascular risk for negative events over the next ten years. This study was registered with The Brazilian Clinical Trials Registry (ReBEC) under registration number: RBR-4c53f3m.
- ItemImpacto do serviço de acompanhamento farmacoterapêutico nos desfechos em saúde de pacientes com hipertensão arterial: protocolo de ensaio clínico e dados preliminares(Universidade Federal do Espírito Santo, 2023-08-21) Vieira, Maria Paula Debona; Santos Junior, Genival Araújo dos; https://orcid.org/0000000256181846; http://lattes.cnpq.br/5917097187533724; https://orcid.org/0009-0003-0261-6239; http://lattes.cnpq.br/6124466867030276; Borba, Helena Hiemisch Lobo; https://orcid.org/0000-0001-9723-584X; http://lattes.cnpq.br/9205414489911034; Batista, Tatianne Mota; https://orcid.org/0000-0003-3240-2613; http://lattes.cnpq.br/2980899910202014Introduction: Hypertension is a chronic health condition that usually requires the use of medication; however, this use is not risk-free. In this scenario, medication therapy management. is a strategy that can improve the health outcomes of people with hypertension. Despite this, there are few studies with high scientific evidence on this topic. Objective: To evaluate preliminary data on the impact of the Comprehensive Medication Therapy service on the health outcomes of patients with hypertension. Methods: This study was carried out in two stages. The first consisted of the elaboration of a protocol for a randomized clinical trial, from June to December 2021. The second stage was the preliminary six-month evaluation of patients with hypertension. The patients who met the eligibility criteria were randomly allocated in a 1:1 ratio to the intervention or control group, who received medication therapy management and usual care, respectively, for 12 months. Both groups had their primary outcomes (baseline blood pressure and quality of life) and secondary outcomes (knowledge about pharmacotherapy; knowledge about hypertension and medication adherence; anthropometric profile, and clinical outcomes) assessed at two time points with a six-month interval between them. Ethical considerations were observed (CAAE: 13586319.6.0000.8151 | Approval nº 4.732.878). Statistical analyzes were performed using Student's t test for independent samples, investigating the difference in the means of the outcomes evaluated between the intervention and control groups at T0 (baseline) and T6. Results: In the first stage, a single-blind randomized clinical trial protocol was proposed, following the recommendations of the Standard Protocol Items: Recommendations for Interventional Trials and the Consolidated Standards of Reporting Trials, which was registered in The Brazilian Clinical Trials Registry (ReBEC) (registration number RBR-4c53f3m). In the second stage, the preliminary evaluation showed that six months after the start of the study, no significant differences were found in any of the studied variables when comparing the control group and the intervention group. However, when performing intragroup analyses, it was possible to observe that patients in the intervention group had improvements in laboratory tests and quality of life after six months of follow-up, with a decrease in systolic blood pressure (-8.50 mmHg, p=0.04), total cholesterol (-11.94 mg/dL, p=0.05), and LDL (-12.21 mg/dL, p=0.01). They also had an increase in knowledge about hypertension (1.62, p=0.001), and improvement in quality of life (MINICHAL) in two parameters, mental (2.79 p=0.02) and somatic manifestations (1.62 p=0.03). Conclusion: In the preliminary 6-month analysis, statistically significant differences were found when comparing the control and intervention groups. The changes observed in the intervention group indicate a positive outcome related to the pharmacotherapeutic follow-up service, with the potential for further improvement in the results when the analysis is performed at 12 months.